news & events
ysios portfolio archive
30.03.17
Aura Biosciences Announces Initiation of Phase 1b Clinical Trial and Receipt of FDA Fast Track Designation for AU-011 for the Treatment of Primary Ocular Melanoma
23.03.17
BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital
22.03.17
Minoryx Therapeutics successfully completes phase 1 clinical trial for lead candidate MIN-102
20.03.17
MedLumics Secures 34.4 Million Euros in Series B Funding
13.03.17
TiGenix Announces Top-Line Phase I/II Results of AlloCSC-01 in Acute Myocardial Infarction
09.03.17
TiGenix Announces Positive Topline Week-104 Data for Cx601 ADMIRE-CD Trial
07.03.17
TiGenix Receives Positive Feedback from the FDA on Cx601 Global Phase III Trial Protocol
06.03.17
TiGenix Provides Update on Cx601 Marketing Authorization Application procedure in Europe
